Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,890 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A single-center prospective study evaluating the usefulness of artificial intelligence for the diagnosis of esophageal squamous cell carcinoma in a real-time setting.
Tani Y, Ishihara R, Inoue T, Okubo Y, Kawakami Y, Matsueda K, Miyake M, Yoshii S, Shichijo S, Kanesaka T, Yamamoto S, Takeuchi Y, Higashino K, Uedo N, Michida T, Kato Y, Tada T. Tani Y, et al. Among authors: miyake m. BMC Gastroenterol. 2023 May 25;23(1):184. doi: 10.1186/s12876-023-02788-2. BMC Gastroenterol. 2023. PMID: 37231330 Free PMC article. Clinical Trial.
Predictors of stricture after non-circumferential endoscopic submucosal dissection of the esophagus and single-dose triamcinolone injection immediately after the procedure.
Miyake M, Ishihara R, Matsuura N, Ueda T, Okubo Y, Kawakami Y, Tani Y, Yoshii S, Shichijo S, Kanesaka T, Yamamoto S, Takeuchi Y, Higashino K, Uedo N, Michida T, Matsunaga T. Miyake M, et al. Gastrointest Endosc. 2023 Aug;98(2):170-177. doi: 10.1016/j.gie.2023.03.017. Epub 2023 Mar 27. Gastrointest Endosc. 2023. PMID: 36990127
Endoscopic resection for local residual or recurrent cancer after definitive chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.
Tani Y, Ishihara R, Matsuura N, Okubo Y, Kawakami Y, Sakurai H, Nakamura T, Matsueda K, Miyake M, Shichijo S, Maekawa A, Kanesaka T, Yamamoto S, Takeuchi Y, Higashino K, Uedo N, Michida T. Tani Y, et al. Among authors: miyake m. Sci Rep. 2023 Jun 28;13(1):10451. doi: 10.1038/s41598-023-32667-5. Sci Rep. 2023. PMID: 37380631 Free PMC article.
Treatment strategy involving docetaxel plus cisplatin and 5-fluorouracil followed by conversion surgery for locally advanced unresectable/borderline resectable esophageal squamous cell carcinoma.
Igaue S, Nozaki R, Utsunomiya D, Kubo Y, Kubo K, Kurita D, Yamamoto S, Miyake M, Ishiyama K, Oguma J, Kato K, Daiko H. Igaue S, et al. Among authors: miyake m. Dis Esophagus. 2025 Jan 7;38(1):doae114. doi: 10.1093/dote/doae114. Dis Esophagus. 2025. PMID: 39824221
Development of TAR-200: A novel targeted releasing system designed to provide sustained delivery of gemcitabine for patients with bladder cancer.
Daneshmand S, Kamat AM, Shore ND, Meeks JJ, Galsky MD, Jacob JM, van der Heijden MS, Williams SB, Powles T, Chang SS, Catto JWF, Psutka SP, Guerrero-Ramos F, Xylinas E, Miyake M, Simone G, Daniel K, Sweiti H, Cutie C, Necchi A. Daneshmand S, et al. Among authors: miyake m. Urol Oncol. 2025 Jan 15:S1078-1439(24)01044-5. doi: 10.1016/j.urolonc.2024.12.264. Online ahead of print. Urol Oncol. 2025. PMID: 39818460 Review.
1,890 results